Treatment for fibromyalgia
The treatment of fibromyalgia, such as treatments for all diseases, often starts with symptom control. With this condition, the symptoms make a chain of sensitive points along the body. Coupling with extreme fatigue and an inability to sleep and you have riddled a fiction for a very poor quality of life with pain and discomfort.
Cannabis medical treatment for fibromyalgia
The prevalence of fibromyalgia treatment increases as a person ages, but 80-90% of all cases are women. It is known that the symptoms worsen with persistence as it progresses and it is aggravated by time, disease and stress. A cannabinoid profile that is well adapted to this condition has been identified in patients with CBD. It is suggested that patients receive a drug that is rich in CBD. By synergistically coupling a cbd-rich oil with an oil that contains little THC, additional relief is provided to the patients.
According to a report from the National Pain Foundation and National Pain Report, medicinal cannabis has been assessed as one of the most effective treatments for reducing fibromyalgia pain. Many 1,300 patients with fibromyalgia responded that they had tried FDA-approved drugs. One patient explained that there were many more negative side effects for FDA-approved drugs than positive ones.
When asked about the effectiveness of Cymbalta (Duloxetine), 60% of those who tried the drug said that it did not work for them, while 8% said it was very effective. 32% reported that Cymbalta was helping. Of those in the study who have tried Pfizer Lyrica (pregabalin) a huge 61% indicated that there is no relief. 10% reported that Lyrica was very effective, while 29% said it helped.
Savella rating (milnacipran) Forest Laboratories, 68% of those who follow the drug said it did not work. 10% said it was very effective and 22% reported a slight relief.
When comparing the results of the study with those who had tried medicinal cannabis because of their symptoms, 62% said it was very effective. Another 33% said that he helped a little while only 5% reported no relief.